BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6219756)

  • 1. [Gestagens and the treatment of hot flushes in the postmenopausal period].
    Presl J
    Cesk Gynekol; 1983 Feb; 48(1):47-9. PubMed ID: 6219756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
    Wander HE; Kleeberg UR; Gärtner E; Hartlapp J; Scherpe A; Bönisch E; Nagel GA
    Onkologie; 1987 Apr; 10(2):104-6. PubMed ID: 2954006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial experience with centralized care of women with bleeding in the climacteric and postmenopausal period].
    Reslová T; Donát J
    Cesk Gynekol; 1989 Mar; 54(2):101-5. PubMed ID: 2525073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
    Willemse PH; van der Ploeg E; Sleijfer DT; Tjabbes T; van Veelen H
    Eur J Cancer; 1990 Mar; 26(3):337-43. PubMed ID: 2141491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
    Blackledge GR; Latief T; Mould JJ; Spooner D; Morrison M
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1091-4. PubMed ID: 2946584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestational agents in advanced breast cancer: an overview.
    Haller DG; Glick JH
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):2-8. PubMed ID: 3026051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
    Lundgren S; Lønning PE
    J Steroid Biochem; 1990 Jun; 36(1-2):105-9. PubMed ID: 2141886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which hormone therapy should be used in advanced breast carcinoma in males?].
    Lönning PE; Wiedemann G; Kvinnsland S; Lundgren S
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1358-61. PubMed ID: 2970379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate for the prevention of hot flashes.
    Hughes-Davies TH
    N Engl J Med; 1995 Jan; 332(1):64. PubMed ID: 7864968
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of progestational agents for postmenopausal hot flushes.
    Roopnarinesingh S
    Int J Gynaecol Obstet; 1982 Apr; 20(2):133-5. PubMed ID: 6125433
    [No Abstract]   [Full Text] [Related]  

  • 11. Current status of high-dose progestins in breast cancer.
    Abrams JS; Parnes H; Aisner J
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):68-72. PubMed ID: 2148027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
    Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
    Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement of climacteric syndrome with MPA treatment (author's transl)].
    Terzi I; Zagami L; Zanno C
    Ann Osp Maria Vittoria Torino; 1980; 23(7-12):447-51. PubMed ID: 6459049
    [No Abstract]   [Full Text] [Related]  

  • 14. Longterm remission of multiple brain metastases with tamoxifen.
    Pors H; von Eyben FE; Sørensen OS; Larsen M
    J Neurooncol; 1991 Apr; 10(2):173-7. PubMed ID: 1716670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medroxyprogesterone-acetate in gynecologic endocrinology].
    Presl J
    Cesk Gynekol; 1987 Feb; 52(1):60-4. PubMed ID: 2952299
    [No Abstract]   [Full Text] [Related]  

  • 16. Progestational agents in the treatment of breast cancer.
    Carpenter JT
    Cancer Treat Res; 1988; 39():147-56. PubMed ID: 2908605
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
    Smith JA
    J Urol; 1994 Jul; 152(1):132-4. PubMed ID: 8201642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E; Bakke O; Ueland PM
    Cancer Chemother Pharmacol; 1986; 18(3):270-5. PubMed ID: 2948732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diazepam with progestin for effectiveness in suppression of urine spraying behavior in cats.
    Cooper L; Hart BL
    J Am Vet Med Assoc; 1992 Mar; 200(6):797-801. PubMed ID: 1533207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
    Miller AA; Becher R; Schmidt CG
    J Cancer Res Clin Oncol; 1988; 114(2):186-90. PubMed ID: 2965155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.